Skip to content

Clinical observation of zaizaoshengxue capsule in the treatment of Cancer-related anemia

Clinical observation of zaizaoshengxue capsule in the treatment of Cancer-related anemia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001560
Enrollment
Unknown
Registered
2025-08-14
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related anemia

Interventions

Treatment group:Treatment with zaizaoshengxue capsule
control group:According to the elemental iron, 46mg per kilogram of body weight per day
supplement folic acid, adults take 5mg each time, 3 times a day.

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The population with tumor diagnosed by histopathology or cytology; (2) People diagnosed with anemia (see Table 1 for the diagnostic criteria of anemia); (3) Karnofsky Performance Status score is above 70. (4) The estimated survival time is > 3 months. (5) 18 = age = 80 years when signing the informed consent. (6) Voluntarily sign informed consent

Exclusion criteria

Exclusion criteria: (1) Other clinical trials are currently underway; (2) Women who are breastfeeding, pregnant, or planning to become pregnant; (3) Those who are known to be allergic to Zaizaoshengxue Capsules or its contained ingredients; (4) Participated in other drug clinical trials within one month before enrollment. (5) Having taken similar proprietary Chinese medicines or traditional Chinese medicine decoctions within one month before enrollment.

Design outcomes

Primary

MeasureTime frame
Hemoglobin content;syndrome points;

Secondary

MeasureTime frame
Red blood cell count;Hematocrit;Mean Corpuscular Volume; Red Cell Distribution Width;White blood cell count;Lymphocyte Count;Neutrophil Count;platelet count;Plateletcrit ;Mean Platelet Volume;Single syndrome points;

Countries

china

Contacts

Public Contactzhoulei

Longhua Hospital Shanghai University of Traditional Chinese Medicine

lucyzhou100@163.com13641759529

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026